Sonja Nelson, Chief Financial Officer at Ambrx Biopharma, Inc. (AMAM), sold 25,556 shares at $9.82 ($251K) on 2023-10-27, disclosed to the SEC on 2023-10-31.
Scheduled sale ($251k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.82 | 12,778 | $125K | 50.0% |
| 2 | $9.82 | 12,778 | $125K | 50.0% |
| Total | $9.82 avg | 25,556 | $251K | 100% |
| Filing → |